Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Lynch
Thomas J
TJ
Division of Hematology/Oncology, Massachusetts General Hospital, Boston 02114, and University of Colorado Cancer Center, Aurora, USA. tlynch@partners.org
Adjei
Alex A
AA
Bunn
Paul A
PA
Eisen
Tim G
TG
Engelman
Jeffrey
J
Goss
Glenwood D
GD
Haber
Daniel A
DA
Heymach
John V
JV
Jänne
Pasi A
PA
Johnson
Bruce E
BE
Johnson
David H
DH
Lilenbaum
Rogerio C
RC
Meyerson
Matthew
M
Sandler
Alan B
AB
Sequist
Lecia V
LV
Settleman
Jeffrey
J
Wong
Kwok-Kin
KK
Hart
Carol S
CS
D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D008958:Models, Molecular; D047428:Protein Kinase Inhibitors / Q000494:pharmacology
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors